<p>Ingevity（紐約證券交易所代碼：NGVT - 獲取免費報告）在週五發佈給客户和投資者的研究報告中，投資分析師將其目標價格從 55.00 美元上調至 60.00 美元，Benzinga 報道。該公司目前對該股票的評級為 “持平”。Wells Fargo &amp; Company 的目標價格表明，相較於公司之前的收盤價，潛在上漲幅度為 0.91%。</p>
<p>其他分析師最近也對該公司發佈了報告。Zacks Research 在週二將 Ingevity 的評級上調至 “持有”。BMO 資本市場在 12 月 10 日的報告中將 Ingevity 的目標價格從 64.00 美元提高至 70.00 美元，並給予該股票 “跑贏大盤” 的評級。Weiss Ratings 在 10 月 8 日的研究報告中重申了對 Ingevity 股票的 “賣出（d-）” 評級。最後，Wall Street Zen 在 12 月 6 日的研究報告中將 Ingevity 的評級從 “強力買入” 下調至 “買入”。一位股票研究分析師對該股票給予了買入評級，兩位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，該公司目前的共識評級為 “持有”，共識目標價格為 65.00 美元。</p>
<p><strong>閲讀我們最新的 NGVT 股票分析</strong></p>
<h2>Ingevity 股票表現</h2>
<p>週五，NYSE:NGVT 的開盤價為 59.46 美元。該股票的 50 日移動平均價格為 53.35 美元，200 日移動平均價格為 51.19 美元。該公司的市值為 21.4 億美元，市盈率為-32.62，貝塔值為 1.40。該公司的債務與股本比率為 8.39，速動比率為 0.80，流動比率為 1.27。Ingevity 的 52 周低點為 28.49 美元，52 周高點為 61.77 美元。</p>
<p>Ingevity（紐約證券交易所代碼：NGVT - 獲取免費報告）最近在 3 月 24 日發佈了季度財報。該公司報告每股收益（EPS）為 0.78 美元。該公司在本季度的收入為 3.36 億美元。Ingevity 的淨利潤率為-5.14%，股本回報率為 103.69%。作為一個整體，股票分析師預計 Ingevity 在當前財年將發佈 4.45 美元的每股收益。</p>
<h2>機構投資者對 Ingevity 的看法</h2>
<p>幾家對沖基金和其他機構投資者最近買入和賣出了該公司的股票。Amalgamated Bank 在第三季度將其在 Ingevity 的股份提高了 1.7%。Amalgamated Bank 現在擁有 10,593 股該公司的股票，價值 585,000 美元，此前在上個季度購買了額外的 180 股。Wealth Enhancement Advisory Services LLC 在第三季度將其在 Ingevity 的持股增加了 3.1%。Wealth Enhancement Advisory Services LLC 現在擁有 7,823 股該公司的股票，價值 418,000 美元，此前在上個季度購買了額外的 238 股。EverSource Wealth Advisors LLC 在第三季度將其在 Ingevity 的股份提高了 15.7%。EverSource Wealth Advisors LLC 現在擁有 1,870 股該公司的股票，價值 103,000 美元，此前在上個季度購買了額外的 254 股。Advisory Services Network LLC 在第三季度將其在 Ingevity 的持股提高了 4.4%。Advisory Services Network LLC 現在擁有 6,947 股該公司的股票，價值 383,000 美元，此前在上個季度購買了額外的 293 股。最後，BI 資產管理基金公司在第一季度將其在 Ingevity 的持股提高了 21.6%。BI 資產管理基金公司現在擁有 1,670 股該公司的股票，價值 66,000 美元，此前在上個季度購買了額外的 297 股。目前 91.59% 的股票由對沖基金和其他機構投資者持有。</p>
<h2>Ingevity 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Ingevity 公司在北美、亞太地區、歐洲、中東、非洲和南美製造和銷售活性炭產品、衍生特種化學品和工程聚合物。它通過三個部門運營：性能材料、性能化學品和先進聚合物技術。</p>
<h2>特色故事</h2>
<ul>
<li>我們更看好的五隻股票比 Ingevity 更好</li>
<li>道瓊斯工業平均指數（DJIA）是什麼？</li>
<li>Rocket Lab 的強勁反彈：近期動能背後的原因</li>
<li>特殊目的收購公司（SPAC）你需要知道的事項</li>
<li>Jabil 在雷達下飛行——但可能會迎來 50% 的激增</li>
<li>如何購買黃金股票並投資黃金</li>
<li>高通的巨大反彈有一個隱患——股票能否繼續上漲？</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Ingevity 嗎？</h2>
<p>在你考慮 Ingevity 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Ingevity 並不在名單上。</p>
<p>雖然 Ingevity 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

NGVT

<p>富國銀行將 Ingevity 股票的目標價從 55.00 美元上調至 60.00 美元，維持 “持平” 評級。其他分析師的評級各不相同，普遍維持 “持有” 評級，目標價為 65.00 美元。Ingevity 的股票開盤價為 59.46 美元，市值為 21.4 億美元。機構投資者持有 91.59% 的股份。該公司在性能材料、性能化學品和先進聚合物技術領域運營</p>

<p>Ingevity (NYSE:NGVT - Get Free Report) had its price target raised by investment analysts at Wells Fargo &amp; Company from $55.00 to $60.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm presently has an &#34;equal weight&#34; rating on the stock. Wells Fargo &amp; Company's price objective would indicate a potential upside of 0.91% from the company's previous close.</p>
<div class="lb-trans"><p>Ingevity（紐約證券交易所代碼：NGVT - 獲取免費報告）在週五發佈給客户和投資者的研究報告中，投資分析師將其目標價格從 55.00 美元上調至 60.00 美元，Benzinga 報道。該公司目前對該股票的評級為 “持平”。Wells Fargo &amp; Company 的目標價格表明，相較於公司之前的收盤價，潛在上漲幅度為 0.91%。</p>
</div><p>Other analysts also recently issued reports about the company. Zacks Research upgraded Ingevity to a &#34;hold&#34; rating in a report on Tuesday. BMO Capital Markets increased their price target on Ingevity from $64.00 to $70.00 and gave the stock an &#34;outperform&#34; rating in a report on Wednesday, December 10th. Weiss Ratings restated a &#34;sell (d-)&#34; rating on shares of Ingevity in a research note on Wednesday, October 8th. Finally, Wall Street Zen downgraded shares of Ingevity from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a research report on Saturday, December 6th. One equities research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of &#34;Hold&#34; and a consensus price target of $65.00.</p>
<div class="lb-trans"><p>其他分析師最近也對該公司發佈了報告。Zacks Research 在週二將 Ingevity 的評級上調至 “持有”。BMO 資本市場在 12 月 10 日的報告中將 Ingevity 的目標價格從 64.00 美元提高至 70.00 美元，並給予該股票 “跑贏大盤” 的評級。Weiss Ratings 在 10 月 8 日的研究報告中重申了對 Ingevity 股票的 “賣出（d-）” 評級。最後，Wall Street Zen 在 12 月 6 日的研究報告中將 Ingevity 的評級從 “強力買入” 下調至 “買入”。一位股票研究分析師對該股票給予了買入評級，兩位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，該公司目前的共識評級為 “持有”，共識目標價格為 65.00 美元。</p>
</div><p><strong>Read Our Latest Stock Analysis on NGVT</strong></p>
<div class="lb-trans"><p><strong>閲讀我們最新的 NGVT 股票分析</strong></p>
</div><h2>Ingevity Stock Performance</h2>
<div class="lb-trans"><h2>Ingevity 股票表現</h2>
</div><p>NYSE:NGVT opened at $59.46 on Friday. The stock has a fifty day moving average price of $53.35 and a 200-day moving average price of $51.19. The company has a market cap of $2.14 billion, a price-to-earnings ratio of -32.62 and a beta of 1.40. The company has a debt-to-equity ratio of 8.39, a quick ratio of 0.80 and a current ratio of 1.27. Ingevity has a fifty-two week low of $28.49 and a fifty-two week high of $61.77.</p>
<div class="lb-trans"><p>週五，NYSE:NGVT 的開盤價為 59.46 美元。該股票的 50 日移動平均價格為 53.35 美元，200 日移動平均價格為 51.19 美元。該公司的市值為 21.4 億美元，市盈率為-32.62，貝塔值為 1.40。該公司的債務與股本比率為 8.39，速動比率為 0.80，流動比率為 1.27。Ingevity 的 52 周低點為 28.49 美元，52 周高點為 61.77 美元。</p>
</div><p>Ingevity (NYSE:NGVT - Get Free Report) last released its quarterly earnings results on Friday, March 24th. The company reported $0.78 earnings per share (EPS) for the quarter. The firm had revenue of $336.00 million during the quarter. Ingevity had a negative net margin of 5.14% and a positive return on equity of 103.69%. As a group, equities analysts anticipate that Ingevity will post 4.45 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Ingevity（紐約證券交易所代碼：NGVT - 獲取免費報告）最近在 3 月 24 日發佈了季度財報。該公司報告每股收益（EPS）為 0.78 美元。該公司在本季度的收入為 3.36 億美元。Ingevity 的淨利潤率為-5.14%，股本回報率為 103.69%。作為一個整體，股票分析師預計 Ingevity 在當前財年將發佈 4.45 美元的每股收益。</p>
</div><h2>Institutional Investors Weigh In On Ingevity</h2>
<div class="lb-trans"><h2>機構投資者對 Ingevity 的看法</h2>
</div><p>Several hedge funds and other institutional investors have recently bought and sold shares of the business. Amalgamated Bank raised its stake in shares of Ingevity by 1.7% in the 3rd quarter. Amalgamated Bank now owns 10,593 shares of the company's stock valued at $585,000 after purchasing an additional 180 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in Ingevity by 3.1% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 7,823 shares of the company's stock valued at $418,000 after buying an additional 238 shares during the last quarter. EverSource Wealth Advisors LLC raised its stake in Ingevity by 15.7% during the third quarter. EverSource Wealth Advisors LLC now owns 1,870 shares of the company's stock valued at $103,000 after buying an additional 254 shares in the last quarter. Advisory Services Network LLC lifted its holdings in Ingevity by 4.4% during the 3rd quarter. Advisory Services Network LLC now owns 6,947 shares of the company's stock worth $383,000 after buying an additional 293 shares during the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S lifted its holdings in Ingevity by 21.6% during the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 1,670 shares of the company's stock worth $66,000 after buying an additional 297 shares during the last quarter. 91.59% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>幾家對沖基金和其他機構投資者最近買入和賣出了該公司的股票。Amalgamated Bank 在第三季度將其在 Ingevity 的股份提高了 1.7%。Amalgamated Bank 現在擁有 10,593 股該公司的股票，價值 585,000 美元，此前在上個季度購買了額外的 180 股。Wealth Enhancement Advisory Services LLC 在第三季度將其在 Ingevity 的持股增加了 3.1%。Wealth Enhancement Advisory Services LLC 現在擁有 7,823 股該公司的股票，價值 418,000 美元，此前在上個季度購買了額外的 238 股。EverSource Wealth Advisors LLC 在第三季度將其在 Ingevity 的股份提高了 15.7%。EverSource Wealth Advisors LLC 現在擁有 1,870 股該公司的股票，價值 103,000 美元，此前在上個季度購買了額外的 254 股。Advisory Services Network LLC 在第三季度將其在 Ingevity 的持股提高了 4.4%。Advisory Services Network LLC 現在擁有 6,947 股該公司的股票，價值 383,000 美元，此前在上個季度購買了額外的 293 股。最後，BI 資產管理基金公司在第一季度將其在 Ingevity 的持股提高了 21.6%。BI 資產管理基金公司現在擁有 1,670 股該公司的股票，價值 66,000 美元，此前在上個季度購買了額外的 297 股。目前 91.59% 的股票由對沖基金和其他機構投資者持有。</p>
</div><h2>Ingevity Company Profile</h2>
<div class="lb-trans"><h2>Ingevity 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.</p>
<div class="lb-trans"><p>Ingevity 公司在北美、亞太地區、歐洲、中東、非洲和南美製造和銷售活性炭產品、衍生特種化學品和工程聚合物。它通過三個部門運營：性能材料、性能化學品和先進聚合物技術。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>特色故事</h2>
</div><ul>
<li>Five stocks we like better than Ingevity</li>
<li>What is the Dow Jones Industrial Average (DJIA)?</li>
<li>Rocket Lab's Sharp Rebound: What's Behind the Recent Momentum</li>
<li>Special Purpose Acquisition Company (SPAC) What You Need to Know</li>
<li>Jabil Is Flying Under the Radar—But a 50% Surge May Be Coming</li>
<li>How to Buy Gold Stock and Invest in Gold</li>
<li>Qualcomm’s Monster Rally Has a Catch—Can the Stock Keep Climbing?</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比 Ingevity 更好</li>
<li>道瓊斯工業平均指數（DJIA）是什麼？</li>
<li>Rocket Lab 的強勁反彈：近期動能背後的原因</li>
<li>特殊目的收購公司（SPAC）你需要知道的事項</li>
<li>Jabil 在雷達下飛行——但可能會迎來 50% 的激增</li>
<li>如何購買黃金股票並投資黃金</li>
<li>高通的巨大反彈有一個隱患——股票能否繼續上漲？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Ingevity Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Ingevity 嗎？</h2>
</div><p>Before you consider Ingevity, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Ingevity 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ingevity wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Ingevity 並不在名單上。</p>
</div><p>While Ingevity currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Ingevity 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

富國銀行公司預測 Ingevity（NYSE:NGVT）股票將迎來強勁的價格升值